[DAYS_LEFT] days left of your Medeconomics free trial

Subscribe now

Your free trial has expired

Subscribe now to access Medeconomics

Flu and pneumococcal immunisation programmes 2015/16

What practices need to do to deliver the flu and pneumococcal enhanced services, including details of this year's flu vaccines.

(Picture: iStock)
(Picture: iStock)

Key points to note

  • The main change to the influenza programme this year is the offer of flu vaccination to children in years 1 and 2 at school. This is likely to be done via schools.
  • Frontline health and social care works should be offered flu vaccination by their employer. This includes general practice staff.
  • It is worth making sure receptionists know the following if any patients are unsure about having the vaccination:
    Last year’s flu vaccination provided low protection against one particular sub type of flu H3N2. This was because a new strain of flu emerged after the flu vaccine had been developed. Selection of strains for inclusion in the vaccine is made by the World Health Organisation each year in February, these strains are those predicted to circulate in the coming season. Throughout the past decade there has generally been a good match between the strains of flu virus in the vaccine and those that subsequently circulated. Flu vaccination remains the best way to protect people from flu.  

Pneumococcal Immunisation enhanced service

Runs from 1 April 2015 to 31 March 2016.

Payment is £7.64 per dose.

At risk groups:

  • Aged 65 and over
  • Aged 2 to 64 and in an at risk group

Patients should be vaccinated on either a proactive call basis if not at risk or a proactive call and recall basis if considered at risk.

Only one dose is required, except for individuals with no spleen, splenic dysfunction or chronic renal disease who require boosters every five years. The guidance says that for these patients practices should contact their area team to reach local agreement on giving boosters. When agreement is reached achievement on CQRS can be manually adjusted.

Practices should sign up for this service (and receive written confirmation from NHS England) by 31 July. The expectation is that practices will deliver both influenza and pneumococcal vaccinations.

Practices will monitor and report activity information via ImmForm. Practices will also need to sign up to the service and manually input data on CQRS.

The following codes should be used:

  Read v2 Read CTV3

Pneumococcal vaccination given

65720

XaCKa

Pneumococcal vaccination

6572

6572

Pneumococcal vaccination contra-indicated

8I2E

XalOS

Pneumococcal vaccination declined

8I3Q

XaIyy

No consent pneumococcal vaccination

68NX

68NX

Pneumococcal vaccination given by other healthcare provider

657P

XaPyX

A full list of read codes by vaccine can be found here in the technical guidance.

Claims must be made monthly on CQRS within 12 days of the end of the month. Where there is an automated data collection there is a five-day period following the month end to allow practices to record the previous month’s activity before the collection occurs. Activity recorded after the collection period is closed will not be collected so practices must ensure all activity is recorded by the cut off date to ensure payment.

NHS England will be responsible for post payment verification which may include an audit of claims.

Influenza immunisation enhanced service

Runs from 1 September 2015 to 31 March 2016.

Practices will be paid £7.64 per dose.

In 2015/16 the following are eligible for flu vaccination:

  • Those aged 65 and over
  • Those aged 6 months to under 65 in clinical risk groups
  • Pregnant women
  • All 2, 3, 4 year olds but not 5 years or older on 31 August 2015
  • All children in school years 1 and 2
  • Those in long stay residential care homes
  • Carers

Fluenz Tetra is the recommended influenza vaccine for children aged six months to 17 and is administered as a nasal spray. Fluenz Tetra is supplied centrally and practices should record all administered doses on ImmForm. This vaccine has a short shelf-life and it is expected that the latest expiry date will be around January or February.

For children where Fluenz Tetra is contra-indicated practices will be centrally supplied with an alternative inactivated flu vaccine.  

For all other eligible patients one of the inactivated influenza vaccines listed below should be used and practices should order these direct from the manufacturers.

Vaccines for 2015/16 flu immunisation programme
Supplier Name of product Vaccine type Age indications Contact details

AstraZeneca UK Ltd

Fluenz Tetra

Live attenuated, nasal

From 24 months to less than 18 years of age

0845 139 0000

BGP Products Ltd, formerly Abbott Healthcare*

Influvac®

Surface antigen, inactivated virus

From six months

0800 358 7468

Imuvac®

Surface antigen, inactivated virus

From six months

GSK

Fluarix Tetra

Split virion inactivated virus

From three years

0800 221 441

MASTA

Imuvac®

Surface antigen, inactivated virus

From six months

0113 238 7552

Inactivated Influenza Vaccine (Split Virion) BP

Split virion, inactivated virus

From six months

Agrippal®

Surface antigen, inactivated virus

From six months

Novartis Vaccines

Agrippal®

Surface antigen, inactivated virus

From six months

08457 451 500

Optaflu®

Surface antigen, inactivated virus, prepared in cell cultures

From 18 years

Pfizer Vaccines

CSL Inactivated Influenza Vaccine

Split virion, inactivated virus

From five years

0800 089 4033

Enzira®

Split virion Inactivated virus

From five years

Sanofi Pasteur MSD

Inactivated Influenza Vaccine (Split Virion) BP

Split virion, inactivated virus

From six months

0800 085 5511

Intanza® 15μg

Split virion, inactivated virus

60 years of age and over

Information in this table is taken from the annual flu immunisation programme supporting letter for 2015/16

Practices should sign up to and agree participation in writing by 31 July 2015 and also need to sign up to CQRS and GPES (if not already).

Patients should be vaccinated on a proactive call basis if not at risk or a proactive call and recall basis if considered at risk, with the aim of maximising uptake in at-risk patients

Patients aged 6 months to 8 years (not reached their 9th birthday) at the time of vaccination, who are defined as at-risk and who have not received influenza vaccine previously, will require a second dose of either Fluenz or an inactivated influenza vaccine at least four weeks after the first dose.

Practices will need to report activity information via ImmForm on a monthly basis. The flu Read codes are not yet available.

Practices have to to manually input data into CQRS until GPES is available. When GPES is available it will capture data for all payment and management information counts and report on activities from the start of the reporting period.

Claims must be made monthly on CQRS within 12 days of the end of the month. Where there is an automated data collection there is a five-day period following the month end to allow practices to record the previous month’s activity. Activity recorded after the collection period is closed will not be collected

No claim for reimbursement of vaccine costs or personal administration fee apply to vaccinations in under 18 because the vaccine is supplied centrally.

NHS England will be responsible for post-payment verification which may include an audit of claims.

  • Fionnuala O'Donnell is a practice manager in Ealing, West London, and a CCG board member.

Useful links

Have you registered with us yet?

Register now to enjoy more articles
and free email bulletins.

Sign up now
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.